Docusate Sodium
Product Images NDC 51655-342

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Docusate Sodium (NDC 51655-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-342-20 (51655 342 20)

Docusate Sodium 100 MG capsules packaging label from Northwind Pharmaceuticals, NDC 51655-342-20. The label indicates a package of 20 capsules, OTC status, and includes lot number, expiration date, active ingredient strength, and storage instructions. The label also lists related drug facts and repackaging information.*

FDA Label Image

51655-342-25 (51655 342 25)

Label for Docusate Sodium 100 MG capsules, containing 60 capsules per package. The label includes dosage instructions, storage directions, lot number NWQ0520001, and expiration date 06/2016. It identifies Northwind Pharmaceuticals as the labeler and provides medication ingredient details and storage warnings.*

FDA Label Image

51655-342-52 (51655 342 52)

Label for Docusate Sodium 100 MG capsules by Northwind Pharmaceuticals shows 30 capsules in the package. The label includes dosage strength, lot number, expiration date, and storage instructions, with additional NDC codes and manufacturer information in Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.